Asunto(s)
Fenómenos Bioquímicos , Teratoma , Humanos , Metilación de ADN/genética , Proteoma/genética , Teratoma/genética , MutaciónRESUMEN
PURPOSE: Advanced testicular germ cell tumours (GCT) generally have a good prognosis owing to their unique sensitivity towards cisplatin-based chemotherapies. However, cisplatin-resistant GCT have a poor outcome. Further studies are mandatory to better understand resistance mechanisms and develop therapeutic strategies for refractory GCTs. METHODS: Protein levels in cisplatin-resistant GCT cell lines of NTERA-2, NCCIT and 2102EP were analyzed by quantitative proteomic mass spectrometry (MS) in combination with stable isotope labelling by amino acids in cell culture (SILAC). Differentially abundant protein markers of acquired cisplatin resistance were validated by Western blotting. Comprehensive bioinformatical annotation using gene set enrichment analyses (GSEA) and STRING interaction analysis were performed to identify commonly affected pathways in cisplatin resistance and the data were compared to the GCT cohort of the 'The Cancer Genome Atlas'. RESULTS: A total of 4375 proteins were quantified by MS, 144 of which were found to be differentially abundant between isogenic resistant and sensitive cell line pairs (24 proteins for NTERA-2, 60 proteins for NCCIT, 75 proteins for 2102EP). Western blotting confirmed regulation of key resistance-associated proteins (CBS, ANXA1, LDHA, CTH, FDXR). GSEA revealed a statistically significant enrichment of DNA repair-associated proteins in all three resistant cell lines and specific additional processes for individual cell lines. CONCLUSION: High resolution MS combined with SILAC is a powerful tool and 144 significantly deregulated proteins were found in cisplatin-resistant GCT cell lines. Our study provides the largest proteomic in vitro library for cisplatin resistance in GCT, yet, enabling further studies to develop new treatment options for patients with refractory GCT.
Asunto(s)
Antineoplásicos , Neoplasias de Células Germinales y Embrionarias , Neoplasias Testiculares , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Línea Celular Tumoral , Cisplatino/farmacología , Cisplatino/uso terapéutico , Resistencia a Antineoplásicos , Humanos , Masculino , Espectrometría de Masas , Neoplasias de Células Germinales y Embrionarias/tratamiento farmacológico , Proteómica , Neoplasias Testiculares/tratamiento farmacológico , Neoplasias Testiculares/patologíaRESUMEN
BACKGROUND AND PURPOSE: Adenoid cystic carcinomas (ACC) are characterized by high rate of local recurrence and late distant metastasis. Chromosomal changes in the evolution from primary tumors to metastatic disease of ACC have not been appointed. Here we investigated the chromosomal alterations of 53 primary tumors from ACC patients with different progressive states by shallow whole genome sequencing to identify potential new markers for metastatic spread. METHODS: Illumina paired-end libraries were generated using DNA from the primary tumor of 53 ACC patients. Fragmented DNA was end-repaired, A-tailed and multiplex sequencing adapters were ligated. Sequence data were mapped to HG19 and a copy-number analysis was conducted using the QDNAseq R package (version 1.10.0). Outliers were removed and data was smoothed by applying the circular binary segmentation algorithm implemented in the R package copynumber version 1.22.0. A modified chromosomal instability (CNI) score was used to analyze deletions and amplifications. RESULTS: Cluster analysis of the whole genome sequencing revealed that the frequency of chromosomal aberrations were increased in ACC with local recurrence and distant metastases in comparison to ACC patients with no metastatic spread. Specifically, chromosome 6 and 12 and exclusively the entire chromosome 4 showed an increased frequency of chromosomal alterations with tumor progression. CONCLUSION: Our data show a molecular evolution from primary tumors to local recurrences and distant metastases and pinpoint the critical chromosomal regions involved in this process. These regions should be in the focus of the search for therapeutic targets of progressive ACC.
Asunto(s)
Carcinoma Adenoide Quístico/genética , Neoplasias de las Glándulas Salivales/genética , Secuenciación Completa del Genoma/métodos , Carcinoma Adenoide Quístico/patología , Aberraciones Cromosómicas , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Neoplasias de las Glándulas Salivales/patologíaRESUMEN
BACKGROUND: Technical advancement and availability of high-throughput analysis has advanced molecular subtyping of most cancers. Thus, new possibilities for precision oncology have emerged. AIM: Therefore, we aimed to collect data regarding availability and use of next generation sequencing (NGS) for urothelial cancer within the uropathology working group of the German Society of Pathology. METHODS: We collected data by questionnaires and additionally asked for sequencing results of bladder cancers in the participating institutions. RESULTS: A total of 13 university-affiliated institutes of pathology took part in the survey. All university institutes offer NGS-based molecular panel diagnostics and provide panels covering between 15 and 170 genes. Altogether, only 20 bladder cancers were sequenced in routine diagnostics and for 10 cancers potential targeted treatment options were available. DISCUSSION: So far, despite availability of NGS diagnostics at university institutes of pathology, only few bladder cancer samples have been sequenced. Based on current data from the molecular subtyping of bladder cancers, we recommend a step-by-step protocol with basic immunohistochemistry analysis and subsequent subtype-dependent analyses, e.g., alterations of the fibroblast growth factor receptors (FGFR) or comprehensive gene panel analyses.
Asunto(s)
Secuenciación de Nucleótidos de Alto Rendimiento , Medicina de Precisión , Humanos , Mutación , Patología Molecular , Encuestas y Cuestionarios , Neoplasias de la Vejiga Urinaria/genética , Neoplasias de la Vejiga Urinaria/patologíaRESUMEN
BACKGROUND: We report a case of multiple keratocysts first diagnosed in an 8-year-old boy. CASE REPORT: The incidental radiographic finding of a cystic lesion in an 8-year-old boy led to the surgical enucleation and further diagnosis of a keratocyst associated with a tooth crown. In the course of dental maturation from deciduous to permanent teeth, the boy presented new lesions, always associated with the crowns of teeth. Gorlin-Goltz (nevoid basal-cell carcinoma) syndrome was suspected, and the genetic analysis detected a previously undescribed germline variant in the PTCH1 gene. TREATMENT: This included a surgical removal of the cystic lesions, as well as the affected teeth. FOLLOW-UP: Due to the high recurrence rate of the keratocysts, frequent radiological checks were performed over a 5-year period.
RESUMEN
Today, tumour classification has been expanded due to immunohistochemical and molecular-pathological analyses due to corresponding patterns/profiles of protein and gene expression. The latter analyses often include growth factors and their ligands, intracellular signalling pathways, DNA-binding proteins, and oncogenes and suppressor genes, thus functionally including primarily the regulation of growth including angiogenesis and apoptosis as well as the induction of metastases to adhesion and migration disorders. Based on observations that testicular tumours often show microcalcifications, possibly due to impaired calcium metabolism, we focused on calcium-dependent transmembrane proteins, particularly cadherins, in the search for new tumour markers and therapeutic targets. Ncadherin is expressed differently in the various subtypes of germ cell tumours and is useful in Ncadherin-positive germ cell tumours as a novel therapeutic targeting structure, particularly in cisplatin resistance, due to functional analysis. In the tumours of the sex cord stroma beta-catenin and the transcription factor SOX-9 give a clear classification of these tumours. Thus, morphological investigations prove to be pilot experiments to purposefully narrow the spectrum of functionally important proteins and thus to establish promising new differential diagnostic markers or target structures.
Asunto(s)
Proteínas de Unión al ADN , Neoplasias de Células Germinales y Embrionarias , Neoplasias Testiculares , Biomarcadores de Tumor , Cadherinas , Proteínas de Unión al ADN/análisis , Humanos , Masculino , Neoplasias de Células Germinales y Embrionarias/diagnóstico , Neoplasias de Células Germinales y Embrionarias/terapia , Neoplasias Testiculares/diagnóstico , Neoplasias Testiculares/terapia , beta CateninaRESUMEN
The WHO classification of testis tumours includes the group of sex cord-stromal tumours. They are divided into several histological types, i.e. Leydig cell (LCT) and Sertoli cell tumours (SCT). Based on the physiological expression of ß-catenin in normal testis/Sertoli cells, it was previously shown that SCT can carry a ß-catenin mutation, causing a nuclear positivity for ß-catenin and cyclin D1. Furthermore, it could be shown that the stabilization of ß-catenin in Sertoli cells causes the loss of the Sertoli cell marker SOX9. We wanted to know whether the stabilization of ß-catenin in sex cord-stromal tumours influences SOX-9 expression and thus could be used in the diagnosis of sex cord-stromal tumours. Therefore, 53 cases of sex cord-stromal tumours and tumour-like lesions were investigated for their immunohistochemical expressions of ß-catenin, cyclin D1 and SOX9. In addition, mutation analyses of the ß-catenin gene (exon 3; CTNNB1) were performed. ß-catenin mutation in SCT results in nuclear ß-catenin and cyclin-D1 expressions on immunohistochemical analysis. The nuclear expression/stabilization of ß-catenin causes the loss of SOX9 in these tumours. In contrast, SOX9 is considerably expressed in non-mutated SCT as well as in Sertoli cells of non-neoplastic testes. In summary, immunohistochemical analyses of ß-catenin and SOX9 are useful to distinguish SCT from other sex cord-stromal tumours of the testis. Furthermore, the presence of SOX9 indicates that the cells of origin may be Sertoli cells.
Asunto(s)
Biomarcadores de Tumor/análisis , Factor de Transcripción SOX9/biosíntesis , Tumores de los Cordones Sexuales y Estroma de las Gónadas/diagnóstico , Neoplasias Testiculares/diagnóstico , beta Catenina/biosíntesis , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Análisis Mutacional de ADN , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Mutación , Factor de Transcripción SOX9/análisis , Tumores de los Cordones Sexuales y Estroma de las Gónadas/genética , Tumores de los Cordones Sexuales y Estroma de las Gónadas/metabolismo , Neoplasias Testiculares/genética , Neoplasias Testiculares/metabolismo , beta Catenina/análisisRESUMEN
The mediastinum is among the most frequent anatomic region in which germ cell tumors (GCT) arise, second only to the gonads. Mediastinal GCT (mGCT) account for 16 % of all mediastinal neoplasms. Although the morphology and (according to all available data) the molecular genetics of mediastinal and gonadal GCT are identical, a number of unique aspects exist. There is a highly relevant bi-modal age distribution. In pre-pubertal children of both sexes, mGCT consist exclusively of teratomas and yolk sac tumors. The prognosis is generally favorable with modern treatment. In post-pubertal adults, virtually all patients with malignant mGCT are males; the prognosis is more guarded and depends (among other factors) on the histological GCT components and is similar to GCT in other organs. So-called somatic type malignancies (i. e. clonally related, non-germ cell neoplasias arising in a GCT) are much more frequent in mGCT than in other organs, and the association between mediastinal yolk sac tumors and hematological malignancies, such as myelodysplasias and leukemias, is unique to mediastinal tumors. The prognosis of GCT with somatic type malignancies is generally dismal.
Asunto(s)
Neoplasias del Mediastino/diagnóstico , Neoplasias del Mediastino/patología , Neoplasias de Células Germinales y Embrionarias/diagnóstico , Neoplasias de Células Germinales y Embrionarias/patología , Adulto , Factores de Edad , Niño , Diagnóstico Diferencial , Tumor del Seno Endodérmico/clasificación , Tumor del Seno Endodérmico/diagnóstico , Tumor del Seno Endodérmico/patología , Femenino , Humanos , Inmunohistoquímica , Leucemia/clasificación , Leucemia/diagnóstico , Leucemia/patología , Masculino , Neoplasias del Mediastino/clasificación , Síndromes Mielodisplásicos/clasificación , Síndromes Mielodisplásicos/diagnóstico , Síndromes Mielodisplásicos/patología , Neoplasias de Células Germinales y Embrionarias/clasificación , Pronóstico , Factores Sexuales , Teratoma/diagnóstico , Teratoma/patologíaRESUMEN
According to the World Health Organization (WHO) classification Leydig cell tumors, Sertoli cell tumors and granulosa cell tumors of the testes belong to the group of sex cord-stromal tumors. These tumors most frequently occur sporadically but in rare cases can be associated with syndromes. These tumor entities show characteristic morphological changes, which in combination with specific immunohistochemical markers facilitate the diagnosis. Recent results of molecular pathological investigations, especially beta-catenin mutation analysis, allow a better categorization of these tumor entities.
Asunto(s)
Tumor de Células de la Granulosa/patología , Tumor de Células de Leydig/patología , Tumor de Células de Sertoli/patología , Neoplasias Testiculares/patología , beta Catenina/genética , Diagnóstico Diferencial , Expresión Génica/genética , Tumor de Células de la Granulosa/diagnóstico , Tumor de Células de la Granulosa/genética , Humanos , Tumor de Células de Leydig/diagnóstico , Tumor de Células de Leydig/genética , Masculino , Tumor de Células de Sertoli/diagnóstico , Tumor de Células de Sertoli/genética , Neoplasias Testiculares/diagnóstico , Neoplasias Testiculares/genética , Testículo/patologíaRESUMEN
BACKGROUND: Prostate-specific membrane antigen (PSMA) is a promising target for diagnostics and therapy of prostate carcinoma (PCa). Based on the hypothesis that PSMA expression can be modulated by variations in androgen deprivation therapy (ADT), we investigated the binding of a PSMA-directed radiopharmaceutical in vitro in order to get an insight of the interactions between altered premedication and PSMA expression before repetitive PSMA-directed PET/CT for therapy response and targeted therapy implementation. METHODS: The human castration-resistant PCa cell line VCaP (CRPC) was treated with either 1 nmol/L testosterone (T) over 20 passages yielding the androgen-sensitive cell line (revCRPC) or with 5 µmol/L abiraterone acetate (AA) generating the abiraterone-tolerant subtype CRPCAA. In these cell lines, T and AA were varied by either supply or withdrawal of T and AA. PSMA expression of the three cell culture models was detected by Western blot and immunohistochemical staining. For quantitative measurement of tracer uptake, 0.3 nmol/L (68)Ga-labelled PSMA-HBED-CC peptide (100-300 kBq/ml) was added to different treated parallel cultures (n = 9 each). Time-dependent uptake per 10(6) cells of each culture was calculated and evaluated. PSMA mRNA expression was investigated by qPCR. RESULTS: PSMA expression increased dependently on intensified ADT in all three basic cell lines. (68)Ga-PSMA-HBED-CC uptake almost doubled during 3 h in all cell lines (p < 0.01). Compared to the basic cells, pre-incubation with abiraterone for 48 h resulted in a significant increased uptake in CRPC (p < 0.001). In revCRPC, 48-h AA pre-incubation resulted in an eightfold higher uptake after 3 h (p < 0.001). Additional withdrawal of external testosterone increased the uptake up to tenfold (p < 0.01). The increase of PSMA expression upon ADT and AA treatments was confirmed by qPCR and Western blot data. Furthermore, in CRPCAA, 48-h AA withdrawal increased the uptake up to fivefold (p < 0.01). CONCLUSIONS: The investigated three PCa cell culture subtypes represent a serial preclinical model of androgen deprivation therapy as a proxy for clinical situations with differing basal PSMA expression. The uptake of PSMA-binding tracers could be stimulated by therapeutic effective short-term variation in premedication in all stages of ADT response. These complex interactions have to be considered in the interpretation of diagnostic imaging using PSMA ligands as well as in the optimal timing of PSMA-based therapies.
RESUMEN
The group of non-seminomatous germ cell tumors can be morphologically and therapeutically distinguished from the group of seminomas. The group of non-seminomatous germ cell tumors includes embryonal carcinoma, yolk sac tumor, choriocarcinoma and teratoma. All entities can occur rarely in pure form or much more commonly in mixed germ cell tumors consisting of more than one histological type. The non-seminomatous germ cell tumors are also characterized by the appearance of an isochromosome 12p, i(12p) and arise from a common precursor lesion called intratubular germ cell neoplasia of the unclassified type (ITGCNU). Various immunohistochemical markers are used to distinguish the different tumor components in addition to morphological characteristics.
Asunto(s)
Neoplasias de Células Germinales y Embrionarias/patología , Neoplasias Testiculares/patología , Biomarcadores de Tumor/genética , Carcinoma Embrionario/genética , Carcinoma Embrionario/patología , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/patología , Coriocarcinoma/genética , Coriocarcinoma/patología , Trastornos de los Cromosomas/genética , Trastornos de los Cromosomas/patología , Cromosomas Humanos Par 12/genética , Diagnóstico Diferencial , Tumor del Seno Endodérmico/genética , Tumor del Seno Endodérmico/patología , Humanos , Masculino , Neoplasias de Células Germinales y Embrionarias/genética , Teratoma/genética , Teratoma/patología , Neoplasias Testiculares/genética , Testículo/patologíaRESUMEN
According to the World Health Organization (WHO) classification from 2004, sex cord gonadal stromal tumors are divided into Leydig cell tumors, Sertoli cell tumors, granulosa cell tumors, tumors of the thecoma-fibroma group, incompletely differentiated sex cord gonadal stromal tumors, mixed forms of sex cord gonadal stromal tumors and tumors containing both germ cell and sex cord gonadal stromal elements. These tumors can appear sporadically or in combination with hereditary syndromes. To diagnose these rare tumors the combination of characteristic morphological aspects and various immunohistochemical markers is useful. Latest investigations demonstrate the potential role of mutation analyses in the diagnosis of this heterogeneous group of tumors.
Asunto(s)
Tumores de los Cordones Sexuales y Estroma de las Gónadas/patología , Neoplasias Testiculares/patología , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/patología , Análisis Mutacional de ADN , Diagnóstico Diferencial , Fibroma/genética , Fibroma/patología , Tumor de Células de la Granulosa/genética , Tumor de Células de la Granulosa/patología , Humanos , Tumor de Células de Leydig/genética , Tumor de Células de Leydig/patología , Masculino , Pronóstico , Tumor de Células de Sertoli/genética , Tumor de Células de Sertoli/patología , Tumores de los Cordones Sexuales y Estroma de las Gónadas/genética , Neoplasias Testiculares/genética , Testículo/patología , Neoplasia Tecoma/genética , Neoplasia Tecoma/patologíaRESUMEN
Myoglobin is a member of the hemoprotein superfamily, which additionally includes hemoglobin, neuroglobin and cytoglobin. Cytoplasmic localized myoglobin functions as a radical scavenger and prevents hypoxia. Besides muscle tissue MB expression could also be observed in other tissues as well as in different types of cancer. For the correlation between the expression of myoglobin, hypoxia-inducible-factor-1α, and capillary density tissue of 86 different renal cell carcinomas were immunohistochemically stained with myoglobin-specific and hypoxia-inducible-factor-1α-specific antibodies as well as with CD31 antibody. Four different renal carcinoma cell lines were cultivated under hypoxic conditions and the expression of myoglobin and hypoxia-inducible-factor-1α was evaluated by real-time PCR and Western blot. Renal cell carcinoma including clear cell, papillary, and chromophobe subtypes expressed myoglobin with an inverse relationship to capillary density being highly significant for clear cell renal cell carcinoma. For hypoxia-inducible-factor-1α a significant correlation with capillary density could also be observed in clear cell RCC. In renal cell carcinoma cell lines hypoxia induced a significant increase of myoglobin expression up to 62 fold, whereas hypoxia-inducible-factor-1α only increased up to 5 fold. The PCR results of myoglobin expression could be confirmed by Western blot. Myoglobin seems to be a sensitive marker for hypovascularized tumor entities especially during the early phase of hypoxia. Such neoplasias may benefit from an antiangiogenic therapy.
Asunto(s)
Carcinoma Papilar/patología , Carcinoma de Células Renales/patología , Regulación Neoplásica de la Expresión Génica , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Hipoxia/patología , Neoplasias Renales/patología , Mioglobina/metabolismo , Apoptosis , Western Blotting , Carcinoma Papilar/genética , Carcinoma Papilar/metabolismo , Carcinoma de Células Renales/genética , Carcinoma de Células Renales/metabolismo , Proliferación Celular , Femenino , Humanos , Hipoxia/genética , Hipoxia/metabolismo , Subunidad alfa del Factor 1 Inducible por Hipoxia/genética , Técnicas para Inmunoenzimas , Neoplasias Renales/genética , Neoplasias Renales/metabolismo , Masculino , Persona de Mediana Edad , Mioglobina/genética , Estadificación de Neoplasias , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales CultivadasRESUMEN
Leydig cell tumours comprise about 3% of all testicular tumours. The pathogenesis of Leydig cell tumours is still poorly understood. We investigated testis with Leydig cell hyperplasia and Leydig cell tumours for their expression pattern of P- and N-cadherin. We could show a switch of expression of P- and N-cadherin in Leydig cell hyperplasia and Leydig cell tumours in comparison with normal Leydig cells. Cadherins could be established as a new immunohistochemical marker for this testicular tumour entity; their possible role in tumour genesis will be discussed.
Asunto(s)
Antígenos CD/genética , Cadherinas/genética , Hiperplasia/genética , Tumor de Células de Leydig/genética , Células Intersticiales del Testículo/metabolismo , Neoplasias Testiculares/genética , Adulto , Antígenos CD/metabolismo , Cadherinas/metabolismo , Estudios de Casos y Controles , Diagnóstico Diferencial , Expresión Génica , Humanos , Hiperplasia/diagnóstico , Hiperplasia/metabolismo , Hiperplasia/patología , Tumor de Células de Leydig/diagnóstico , Tumor de Células de Leydig/metabolismo , Tumor de Células de Leydig/patología , Células Intersticiales del Testículo/patología , Masculino , Persona de Mediana Edad , Neoplasias Testiculares/diagnóstico , Neoplasias Testiculares/metabolismo , Neoplasias Testiculares/patologíaRESUMEN
Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18-35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. 1,25-Dihydroxyvitamin D (1,25(OH)(2)D(3)) is the active form of vitamin D and exerts its actions via a specific intracellular vitamin D receptor (VDR). Several investigations in the recent years have revealed, in addition to a physiological occurrence of the VDR in various tissues, VDR expression in different human malignancies. Furthermore, 1,25(OH)(2)D(3) plays an important role in the regulation of cell proliferation and differentiation. In different normal and malignant cell types, antiproliferative and pro-differentiating effects of 1,25(OH)(2)D(3) are described. We investigated whether TGCT express the VDR, wether differences exist between the histological subtypes and if vitamin D has a function on the proliferation of tumour cells. Furthermore, we investigated the potential function of the vitamin D-regulated genes nuclear receptor co-repressor 1(NCOR1), nuclear receptor co-repressor 2 (NCOR2), thyroid receptor interacting protein 15 (TRIP15), Growth Arrest and DNA Damage (GADD45), MAP kinase-activated protein kinase 2 (MAPKAPK2), Cytochrome P450, family 24, subfamily A, polypeptide 1 (CYP24A1) and Cytochrome P450, family 27, subfamily B, polypeptide 1 (CYP27B1) in the pathogenesis of TGCT. We demonstrate, for the first time, that primary TGCT as well as TGCT cell lines, express VDR mRNA and protein. Vitamin D and VDR may play a role in the pathogenesis of TGCTs. Furthermore, vitamin D inhibits proliferation of TGCT cell-lines, potentially via an increase in expression of GADD45. Our data suggest that vitamin D could play a role in antitumour therapy.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias de Células Germinales y Embrionarias/metabolismo , Neoplasias de Células Germinales y Embrionarias/patología , Receptores de Calcitriol/metabolismo , Neoplasias Testiculares/metabolismo , Neoplasias Testiculares/patología , Adulto , Biomarcadores de Tumor/genética , Western Blotting , Proliferación Celular , Humanos , Técnicas para Inmunoenzimas , Masculino , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores de Calcitriol/genética , Transducción de Señal , Vitamina D/análogos & derivados , Vitamina D/farmacologíaRESUMEN
Saccades challenge visual perception since they induce large shifts of the image on the retina. Nevertheless, we perceive the outer world as being stable. The saccadic system also can rapidly adapt to changes in the environment (saccadic adaptation). In such case, a dissociation is introduced between a driving visual signal (the original saccade target) and a motor output (the adapted saccade vector). The question arises, how saccadic adaptation interferes with perceptual visual stability. In order to answer this question, we engaged human subjects in a saccade adaptation paradigm and interspersed trials in which the saccade target was displaced perisaccadically to a random position. In these trials subjects had to report on their perception of displacements of the saccade target. Subjects were tested in two conditions. In the 'blank' condition, the saccade target was briefly blanked after the end of the saccade. In the 'no-blank' condition the target was permanently visible. Confirming previous findings, the visual system was rather insensitive to displacements of the saccade target in an unadapted state, an effect termed saccadic suppression of displacement (SSD). In all adaptation conditions, we found spatial perception to correlate with the adaptive changes in saccade landing site. In contrast, small changes in saccade amplitude that occurred on a trial by trial basis did not correlate with perception. In the 'no-blank' condition we observed a prominent increase in suppression strength during backward adaptation. We discuss our findings in the context of existing theories on transsaccadic perceptual stability and its neural basis.
Asunto(s)
Adaptación Ocular/fisiología , Movimientos Sacádicos/fisiología , Percepción Visual/fisiología , Adulto , Discriminación en Psicología/fisiología , Movimientos Oculares/fisiología , Femenino , Humanos , MasculinoRESUMEN
Neurons in cortical medial temporal area (MT) and medial superior temporal area (MST) projecting to the dorsolateral pontine nucleus (DLPN) and/or to the nucleus of the optic tract and dorsal terminal nucleus (NOT-DTN) were identified by antidromic electrical stimulation in five macaque monkeys. Neurons projecting to either target were located in close proximity to each other, and in all subregions of MT and MST sampled. Only a small percentage of the antidromically identified projection neurons (4.4%) sent branches to both the NOT-DTN and the DLPN. Antidromic latencies of neurons projecting to the NOT-DTN (0.9-6 ms, median 2.1 ms) and to the DLPN (0.8-5 ms, median 2.0 ms) did not differ significantly. Visual response properties of the neurons antidromically activated from either site did not differ significantly from those of cells that were not so activated. On the population level only neurons activated from the NOT-DTN had a clear preference for ipsiversive stimulus movement, whereas the neurons activated from the DLPN and neurons not antidromically activated from either target had no common directional preference. These results are discussed in terms of specification of cortico-subcortical connections and with regard to pathways underlying slow eye movements in different visuomotor behaviours.
Asunto(s)
Cerebelo/fisiología , Macaca mulatta/fisiología , Corteza Visual/fisiología , Vías Visuales/fisiología , Potenciales de Acción/fisiología , Animales , Axones/fisiología , Cerebelo/anatomía & histología , Estimulación Eléctrica , Movimientos Oculares/fisiología , Femenino , Macaca mulatta/anatomía & histología , Masculino , Percepción de Movimiento/fisiología , Conducción Nerviosa/fisiología , Neuronas/fisiología , Puente/anatomía & histología , Puente/fisiología , Desempeño Psicomotor/fisiología , Tiempo de Reacción/fisiología , Transmisión Sináptica/fisiología , Lóbulo Temporal/anatomía & histología , Lóbulo Temporal/fisiología , Corteza Visual/anatomía & histología , Vías Visuales/anatomía & histología , Percepción Visual/fisiologíaRESUMEN
Everyday life often necessitates dissociation between our directed attention and the intention to direct our gaze. Accordingly, the differential role of visual and motor related areas in the one or the other process is an issue of an ongoing debate. Here we used functional magnetic resonance imaging to elaborate a differentiation between visuospatial attention and the intention for a horizontal saccade in these cortical areas. Subjects fixated a central target, while they directed their attention to a colored cue in the left or right visual field. Regardless of its location, the color of the cue instructed the direction of the upcoming saccade (intention). The attention to the peripheral cue and the intention to perform the saccade were thus either directed to the same side or to opposite sides. A random effects analysis of the imaging data showed that activation of the early visual cortex and the motion sensitive complex was biased by attention to the contralateral cue, whereas activity of the color sensitive complex was modulated by the stimulus instructing a contraversive saccade. The posterior parietal cortex and the proper supplementary eye field (SEF) were most strongly activated in case of spatially congruent attention and intention. In contrast, activity of the pre-SEF and the frontal eye field was enhanced by spatially divergent attention and intention. The results presented here advance our understanding of how the human brain processes spatial information. Noteworthy, the visuomotor related areas show a subtle cortical separation for visual related attention and saccade related intention.
Asunto(s)
Atención/fisiología , Corteza Cerebral/fisiología , Intención , Movimientos Sacádicos/fisiología , Percepción Espacial/fisiología , Adulto , Análisis de Varianza , Corteza Cerebral/irrigación sanguínea , Señales (Psicología) , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Imagen por Resonancia Magnética/métodos , Masculino , Pruebas Neuropsicológicas , Oxígeno/sangre , Estimulación Luminosa , Desempeño Psicomotor , Tiempo de Reacción , Campos Visuales/fisiologíaRESUMEN
Testicular germ cell tumours (TGCT) represent the most common malignancy in young males. We reported previously that two prototype members of the mitogen-activated protein kinase (MAPK) family, the MAPK ERK kinase (MEK) and extracellular signal-regulated kinase (ERK), are inactive in malignant testicular germ cells and become active after drug stimulation, leading to apoptosis of tumour cells. In this study, we asked whether the protein phosphatase PP2A, a known inhibitor of the MEK-ERK pathway, participates in the proliferation and/or apoptosis of primary TGCT (n = 48) as well as two TGCT cell lines (NTERA and NCCIT). Quantitative RT-PCR, immunohistochemistry, western blot analyses and phosphatase assay indicate that primary TGCT as well as TGCT cell lines express PP2A and that PP2A is active in TGCT cell lines. The inhibition of PP2A by application of two PP2A inhibitors, cantharidic acid (CA) and okadaic acid (OA), results in a significant increase in caspase-3-mediated apoptosis of TGCT cell lines. Thereby, PP2A inhibition was accompanied by phosphorylation and activation of MEK and ERK. Functional assays using the MEK inhibitor PD98059 demonstrated that the phosphorylation of MEK and ERK was required for the induction of caspase-3-mediated apoptosis of malignant germ cells. Thus, our data suggest that inhibition of PP2A mediates its apoptosis-inducing effect on TGCT through activation of the MEK-ERK signalling pathway that leads to caspase-3-mediated apoptosis of tumour cells. In addition our results support previous observations that PP2A exerts an anti-apoptotic effect on malignant tumour cells.